 NEW YORK LONDON PARIS--BUSINESS WIRE--Aptorum Group Limited Nasdaq: APM, Euronext Paris: APM a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren Lui, CEO and Executive Director of Aptorum Group will present both in-person and virtually at the H.C. Wainwright Global Investment Conference, New York, being held on September 13-16, 2022. Aptorum Group management will be 